Team:Heidelberg/Notebook/BSDesign/September

From 2010.igem.org

(Difference between revisions)
(08/09/2010)
Line 144: Line 144:
<br /><br />
<br /><br />
 +
Beside this, it is known that hsa-mir-122 is expressed in liver uniquely, at least for humans. Additionally, mm-mir-375/376a are uniquely expressed in mouse livers. As we are heading for divergent prospective experiments, first we want to show that the principle of using endogenous miRNAs for tissue identification tasks is compatible with our constructs for luciferase measurements (compare to '''[http://2010.igem.org/Team:Heidelberg/Project/miRNA_Kit Synthetic miRNA-Kit]''') and our new measurement standard '''[http://2010.igem.org/Team:Heidelberg/Project/miMeasure miMeasure]'''.
 +
As it is known !!!reference!!! that multiple miRNA binding sites in a row increase the knock-down efficiency of miRNAs, binding patterns may help to find the right threshold for specific tissue targeting.
 +
Therefore we created a spacer sequence by rational design with a GC content of 50%. This spacer need to be as innert as possible, in terms of miRNA recognition, so the sequence was then tested for compatibility with other miRNAs. We found a 30 bp spacer which had low compatiblity to any miRNA given by the tools mentioned. Highest achieved mean free energy was higher than -30 kcal/mol (the higher, the less effective is the binding), whereas a perfect binding miRNA was, in our cases, always under -40 kcal/mol.
 +
 +
Spacer sequence: <span style="color:#009be1">GCATACATGGACTGC</span><span style="color:#78b41e">CACTGAATCCAACTG</span>
 +
 +
For our random assembly PCR approach, we created oligos using this spacer-sequence as annealing site. Therefore we split the spacer in two halfs, and placed a miRNA binding site in between:
 +
:<span style="color:#78b41e">CACTGAATCCAACTG</span>-miRNA binding site-<span style="color:#009be1">GCATACATGGACTGC</span>
 +
 +
This first and second half of he spacer are
 +
 +
Additionally
----
----

Revision as of 14:09, 27 October 2010

 


Binding Site Design - September


08/09/2010

Oligo design for random assembly PCR (raPCR)

Using endogenous miRNAs for cell-identification, a detectable difference in miRNA-expression levels need to be present. Therefore we sent isolated RNA from HeLa, HUH7 and HEK-293 cells either infected with AAV or non-infected to febit for microarray analysation of micro-RNA expression levels. The obtained results were delivered in an evaluated form, showing relative expression levels between the different cell lines and/or conditions. For further experiments, the highest relative differences of two approaches were looked up:

  1. comparison in one cell line between control and AAV infected status
  2. comparison in one condition between different cell lines


1. comparison in one cell line between control and AAV infected status

table 1: relative miRNA expression differences, compared between AAV infected and non-infected cells
AssaymiRNArelative expression difference (log-scale)
HUH Ctr vs HUH AAV hsa-miR-520e -4,68
HUH Ctr vs HUH AAV hsa-miR-126* -3,77
HUH Ctr vs HUH AAV hsa-miR-502-5p 3,79
HUH Ctr vs HUH AAV hsa-miR-1179 4,00
HEK Ctr vs HEK AAV hsa-miR-221 -0,84
HEK Ctr vs HEK AAV hsa-miR-125a-5p -0,64
HEK Ctr vs HEK AAV hsa-miR-3130-3p 0,58
HEK Ctr vs HEK AAV hsa-miR-33bStar 0,59
HeLa Ctr vs HeLa AAV hsa-miR-20a -0,88
HeLa Ctr vs HeLa AAV hsa-miR-93 -0,66
HeLa Ctr vs HeLa AAV hsa-miR-1228 0,84
HeLa Ctr vs HeLa AAV hsa-miR-574-5p 0,92

Positive or negative log-values indicate upregulation or downregulation in AAV infected cells compared to non-infected cells of the same cell type, respectively.



2. comparison in one condition between different cell lines

Here are the most up- and downregulated miRNAs shown. One of those were picked for further experiments.

Identify HUH cells from HeLa/HEK cells:
hsa-miR-574-5p
Assayrelative expression difference (log-scale)
HUH Ctr vs HeLa Ctr -1,00
HUH Ctr vs HEK Ctr -0,71
HeLa Ctr vs HEK Ctr 0,29
hsa-miR-574-5p is downregulated in HeLa and HEK cells, compared to HUH. Comparison between HeLa and HEK shows a relatively small difference in expression level.


hsa-miR-320b
Assayrelative expression difference (log-scale)
HUH Ctr vs HeLa Ctr 1,03
HUH Ctr vs HEK Ctr 1,11
HeLa Ctr vs HEK Ctr 0,07
hsa-miR-320b is upregulated in HeLa and HEK cells, compared to HUH. Comparison between HeLa and HEK shows a relatively small difference in expression level.


As for hsa-miR-320b the expression level between HeLa and HEK cells is closer to each other (compared to hsa-miR-574-5p), hsa-miR-574-5p might be the better choice.



Identify HeLa cells from HEK/HUH cells:
hsa-miR-29a
Assayrelative expression difference (log-scale)
HUH AAV vs HeLa AAV -1,19
HeLa AAV vs HEK AAV 1,3
HUH AAV vs HEK AAV 0,11
hsa-miR-29a is downregulated in HUH and HEK cells, compared to HeLa. Comparison between HUHand HEK shows a relatively small difference in expression level.


hsa-miR-4286
Assayrelative expression difference (log-scale)
HUH Ctr vs HeLa Ctr 0,68
HeLa Ctr vs HEK Ctr -0,68
HUH Ctr vs HEK Ctr 0
hsa-miR-4286 is upregulated in HUH and HEK cells, compared to HeLa. Comparison between HUH and HEK shows no difference in relative expression level.


As there is no difference in the relative expression level detected for hsa-miR-4286, it is a promising choice for further experiments.



Identify HEK cells from HeLa/HUH cells:
hsa-miR-221
Assayrelative expression difference (log-scale)
HUH Ctr vs HEK Ctr -1,13
HeLa Ctr vs HEK Ctr -1,3
HUH Ctr vs HeLa Ctr 0,17
hsa-miR-221 is downregulated in HeLa and HUH cells, compared to HEK. Comparison between HeLa and HUH shows a relatively small difference in expression level.


hsa-miR-125b
Assayrelative expression difference (log-scale)
HUH Ctr vs HEK Ctr 1,22
HeLa Ctr vs HEK Ctr 1,27
HUH Ctr vs HeLa Ctr -0,05
hsa-miR-125b is upregulated in HeLa and HUHcells, compared to HED. Comparison between HeLa and HUH shows a relatively small difference in expression level.


As both miRNAs have similar relative expression levels in HUH and HeLa cells, hsa-miR-221 ist taken to test one downregulated sample



Beside this, it is known that hsa-mir-122 is expressed in liver uniquely, at least for humans. Additionally, mm-mir-375/376a are uniquely expressed in mouse livers. As we are heading for divergent prospective experiments, first we want to show that the principle of using endogenous miRNAs for tissue identification tasks is compatible with our constructs for luciferase measurements (compare to Synthetic miRNA-Kit) and our new measurement standard miMeasure.

As it is known !!!reference!!! that multiple miRNA binding sites in a row increase the knock-down efficiency of miRNAs, binding patterns may help to find the right threshold for specific tissue targeting. Therefore we created a spacer sequence by rational design with a GC content of 50%. This spacer need to be as innert as possible, in terms of miRNA recognition, so the sequence was then tested for compatibility with other miRNAs. We found a 30 bp spacer which had low compatiblity to any miRNA given by the tools mentioned. Highest achieved mean free energy was higher than -30 kcal/mol (the higher, the less effective is the binding), whereas a perfect binding miRNA was, in our cases, always under -40 kcal/mol.

Spacer sequence: GCATACATGGACTGCCACTGAATCCAACTG

For our random assembly PCR approach, we created oligos using this spacer-sequence as annealing site. Therefore we split the spacer in two halfs, and placed a miRNA binding site in between:

CACTGAATCCAACTG-miRNA binding site-GCATACATGGACTGC

This first and second half of he spacer are

Additionally


13/09/2010


Restriction digest of psiCHECK-2 plasmid
This will be used as backbone for raPCR cloning. Enzymes: XhoI and NotI

Assay:

5 µL 10x NEBuffer 3
5 µL 10x BSA
5 µL plasmid (psiCHECK-2, ~370 ng/µL)
3 µL XhoI
1 µL NotI
18.6 µL H2O

Restriction digest was performed for approx. 5h



raPCR to create binding sites for different miRNAs This random assembly PCR (raPCR) will be done to create binding site patterns for the miRNAs mentioned. In the first PCR step the oligos will basically anneal and constructs of different lengths will form. In the second step, the stop oligos are used as primers to amplify the previously formed constructs.

  • first tries are: hsa-mir-122, hsa-mir122(ran9-12) and mm-mir-376a/375 (Oligos: ra001-003 and ra006)

stop-oligos: raPCR_AS13-stop_rev_NotI and raPCR_AS13-stop_fw_XhoI (ra017/018)
spacer: raPCR_AS13-spacer(0) and raPCR_AS13-spacer(10) (ra012/013)

Oligos were used in standard conc. (100µM)

  • 1. PCR
Oligo mir-122 mir-122(ran9-12) mir-375/376a
miR 1 or 3 µL 1 or 3 µL 0.5 or 1.5 µL (each)
spacer(0)or (10) 1 µL 1 µL 1 µL
stop 0 or 0.5 µL each 0 or 0.5 µL each 0 or 0.5 µL each


Total: 12 reactions
each reaction was set up in 30 µL, using 2x Phusion Mastermix for 12 cycles

Temp Time
95°05:00
95°00:30x 12 cycles
57°00:45
72°00:45
forever
  • PCR purification: each PCR was purified using Qiagen PCR purification Kit and eluted in 32 µL

for the next PCR, three assay will tried:

  1. 5µL eluate + 1 µL of each stop oligo in 50µL total volume
  2. 5µL eluate + 2 µL of each stop oligo in 50µL total volume
  3. 20µL eluate + 1 µL of each stop oligo in 50µL total volume

stop-oligos: raPCR_AS13-stop_rev_NotI and raPCR_AS13-stop_fw_XhoI

  • 2. PCR

In total there were 72 reactions. Each was run with 2x Phusion Mastermix, missing volume was filled with water.

Temp Time
95°05:00
95°00:30x 25 cycles
65°00:45
72°00:50
72°05:00
forever

DNA was stored in fridge afterwards






14/09/2010

The 72 PCRs from 13/10/2010 were analysed on 1% agarose gel.

raPCR using a mixture of miRBS-375 and miRBS-376a oligos The initial 8 PCRs from the first raPCR were purified using Qiagen PCR Purification Kit, eluted in 32 µL and used as template for the second raPCR.



File:2010-09-14 - raPCR miR122-klein fertig.png
raPCR using miR-122 oligos The initial 8 PCRs from the first raPCR were purified using Qiagen PCR Purification Kit, eluted in 32 µL and used as template for the second raPCR.
raPCR using miR-122 (ran9-12) oligos The initial 8 PCRs from the first raPCR were purified using Qiagen PCR Purification Kit, eluted in 32 µL and used as template for the second raPCR.
table 1: conditions for 1st raPCR
1. ra PCR condition Template-Oligo [µL] Stop-Oligo [µL] Spacer-Oligo (1µL) [bp]
1100
21010
31100
411010
5300
63010
73100
831010

As we are looking for multiple binding sites, lanes with longest smear, meaning more long binding sites, were choosen for preparative gel:
Over all assay, using 5 µL template and 1µL of each stop-oligo seem to give the best result.
Following lanes were cut out of the gel for further cloning steps:

Spacer(0): lane 5
Spacer(10): lane 6


Samples for miR122 were applied to a preparative agarose gel (1.5%). Lanes were cut out from approx. 100 to 400bp and splitted at ~250bp. Therefore, we should have small binding site patterns (between 100 and 250bp) and larger binding site patterns (betweens 250 and 400bp) with either a shorter (Spacer(0)) or longer (Spacer(10)) spacer region.

Preparative gel for 2. raPCR of miR-122 was cut out in the freamed region.
Preparative gel for 2. raPCR of miR-122 (ran9-12) (1: Spacer(0), 2: Spacer(10)) and miR-275/376a (3: Spacer(0), 4: Spacer(10)) was cut out in the freamed region.

As the gel volume was too much for dissolving in a single 2 mL tube, each part was splitted for dna extraction and brought together on the column. Gel extractions were done according to Qiagen Gel-extraction kit protocal and eluted in 30 µL water.







15/09/2010

Sample code:

Spacer(0)  - 100-250bp:  0S (for zero small)
Spacer(0)  - 250-400bp:  0L (for zero large)
Spacer(10) - 100-250bp: 10S (for ten small)
Spacer(10) - 250-400bp: 10L (for ten large)
this System was used for each raPCR after gel purification

First row of cloning will be done with miR-122 samples. Others will follow.

Samples prepared: 122-0S,-0L,-10S,-10L

Gel extracted samples were digested with NotI/XhoI for cloning into psiCheck-2 vector: 5µL DNA (2µL for backbone) in a total volume of 30µL using 1µL XhoI and 0.6µL NotI enzyme, for 1.5 h at 37°C.

The digested DNA was then purified using Qiagen nucleotide removal kit and eluted in 30µL.

Subsequently, digested fragments were ligated over night at room temperature.

Ligation assay for Fermentas T4 ligase: 2µL Buffer 1µL Ligase 7µL water 1µL Backbone (6000bp, psiCHECK-2) 9µL purified restriction digest






16/09/2010

Transformation of ligations: 5µL ligation assay in 50µL TOP10 E.coli 25 min on ice 45sec heat shock on 42°C 1.5-2h shaking at 37°C

plated 200µL on Ampicillin-LB/Agar-Plates

after incubating ~8h, at 37°C, the plates were incubated overnight at room temperature






17/09/2010

Colonies were visible in reasonable numbers on every plate

Colony PCRs were performed to check for positive clones.

Primer for colony PCR were stop-oligos, used in the raPCR. The PCR was performed in a total volume of 20 µL.

One colony was dissolved in 20µL water. 5µL of this bacteria solution was used as PCR template. PCR conditions as recommended from Fermentas (see link above). From each plate, 10 colonies were picked (40 in total).

Colony PCRs were then analysed on 1.5% agarose gel. Result: all negative

Troubleshooting....

Minipreps were prepared (5mL - LB-ampicillin) for each sample for text digestion (over night, shaking @37°C)






18/09/2010

Plasmid DNA was purified from over night cultures using Qiagen Plasmid Miniprep Kit according to the protocol. Elution was performed in 30 µL water.

Concentrations ranged from approx. 400 to 788 ng/µL.

Test digestion with NotI/XhoI was performed for 1h at @37°C and analysed on an 1.5% agarose gel. No insert was visible.




19/09/2010

Troubleshooting: Possible Problems

  • we got the wrong backbone (given by Stefan M.) -> assure we have the right one
  • backbone was not fully digested -> several test digestions
  • insert was not fully digested -> can not be checked
  • enzymes out of function? -> single digest of the vector can check that
  • ligation did not work -> reaction was performed according to usual lab routine and protocol
  • low transformation efficiency -> reaction was performed according to usual lab routine and protocol
  • bacteria are not competent -> they work for other transformations

Testing steps:

digestion of psiCHECK-2 given by Stefan M.
test-digestion of psiCHECK-2 given by Stefan M. again and compare both
repeat all steps

Over night digestion of backbone was performed at 37°C. 0.5 µg DNA was digested with 1 µL Enzyme in NEB Buffer 3 + BSA in a total volume of 30µL


20/09/2010

Digestion of psiCHECK-2 plasmid was analysed on 1% agarose gel:

Single digest of psiCHECK-2 Plasmid was digestet overnight @37°C with NotI/XhoI using NEB Buffer 3 + BSA in a total volume of 30µL. 1)Digest with NotI 2)Digest with XhoI 3)undigested plasmid

Here we can see that both enzymes cut the plasmid. The linearized vector (visible at 6 kpb) in general shows up as a higher band than its undigested version, which is here visible at 4 kbp. Where the undigested plasmid shows concatemers, those are not visible after digestion, which proofs again for succesful digestion.

The new digested plasmid-backbone was used for repeat of the ligation.


21/09/2010

Ligation was performed for 4h @25°C (1µL NotI/XhoI-linearised psiCHECK2-plasmid + 4µL digested raPCR product) using Fermentas T4 Ligase



28/09/2010

  • send 1.3, 1.5, 1.7, 3.8, 3.2 for sequencing

28/09/2010

  • send 1.3, 1.5, 1.7, 3.8, 3.2 for sequencing

29/09/2010

  • got sequencing results of 1.3, 1.5, 1.7, 2.8, 3.2.
  • 1.3 - 3 binding sites - all ok
  • 1.5 - 2 binding sites - both ok
  • 1.7 - 3 binding sites - all ok
  • 2.8 - not ok

(all those were made with Spacer(0) )

  • 3.7 - 2 binding sites, created by Spacer(10) - both ok seperated by 10 nucleotide spacer

30/09/2010

  • raPCRfrom above(1, 2, 3, 4)
  • PCR purification ( nanodrop: c ˜ 100ng/µl)
  • digested: 2 x 1 µg DNA:
  • EcoRI
  • PstI
  • gel purification (nanodrop: c ˜ 25ng/µl)
  • Ligation (Quick Ligase and overnight ligation with T4 ligase) into pSB1C3
  • Vector ˜ 2000 bp
  • Insert ˜ 200 bp
  • Transformation